United States News Todas as matérias

Lakeland Industries, operating as Lakeland Fire + Safety (NASDAQ:LAKE), reported a return to net profitability for the fiscal first quarter of 2027, driven by robust expansion within its core fire services segment and structural optimization of its product portfolio.

European Union antitrust regulators ordered Meta Platforms (NASDAQ:META) to grant competing artificial intelligence chatbots free access to its WhatsApp messaging service, utilizing emergency interim powers for the first time in 17 years to protect startup developers while a broader market-power investigation proceeds.

Tango Therapeutics (NASDAQ:TNGX) shares climbed to a record high after the company unveiled initial clinical data showing that its experimental oncology asset, vopimetostat, shrunk tumors in nearly all evaluated pancreatic cancer patients when combined with Revolution Medicines' daraxonrasib.

Perma-Pipe International Holdings (NASDAQ:PPIH) reported an expansion in top-line revenue for the first quarter of fiscal year 2026, driven by sustained industrial demand across its primary geographic footprints, though near-term factory start-up friction and heightened regulatory compliance outlays compressed bottom-line margins.

Teleflex (NYSE:TFX) announced positive four-year follow-up data from its First-in-Human BIOMAG-I clinical trial, reinforcing the long-term safety and performance stability of its third-generation Freesolve Resorbable Magnesium Scaffold.

Vivakor (NASDAQ:VIVK) reported a narrower net loss and significantly stronger gross margins for the first quarter of 2026, signaling early progress in the company’s ongoing pivot toward its higher-margin midstream and logistics operations.

Cartesian Therapeutics (NASDAQ:RNAC) announced a strategic licensing agreement with WestGene Biopharma to co-develop innovative in vivo mRNA chimeric antigen receptor T-cell (CAR-T) therapies, marking a significant expansion of its clinical efforts to target severe autoimmune conditions.

BitFuFu (NASDAQ:FUFU) reported a 22.1% month-over-month increase in its unaudited Bitcoin production for May 2026, driven by a deliberate pivot toward its proprietary self-mining business and stabilized infrastructure conditions across its international footprint.

Aditxt (NASDAQ:ADTX) announced that its wholly owned subsidiary, Ignite Proteomics, has entered into a definitive business combination agreement with a strategic counterparty to transition the functional proteomics firm into an independent, publicly traded corporation.

OFS Credit Company (NASDAQ:OCCI) reported a contraction in its net asset value and a decline in quarterly investment income for its fiscal second quarter, driven by yield compression and weaker cash flow dynamics across its structured credit holdings.

TG Therapeutics (NASDAQ:TGTX) reported positive topline results from an early-stage clinical evaluation of a subcutaneous formulation of its flagship therapy, BRIUMVI, in patients with myasthenia gravis, marking a significant milestone in the company’s strategy to expand the drug's utility beyond its approved indication for multiple sclerosis.

RedHill Biopharma (NASDAQ:RDHL) announced that the U.S. Food and Drug Administration has granted rare pediatric disease designation to its investigational asset, opaganib, for the treatment of neuroblastoma, a type of cancer that primarily affects infants and young children.

Invivyd (NASDAQ:IVVD) has initiated dosing in its LIBERTY Phase 3 clinical trial, a randomized, double-blind study designed to evaluate the safety, tolerability, and immunology of its investigational monoclonal antibody candidate, VYD2311, alone and co-administered with an mRNA COVID-19 vaccine in healthy adults.

Alterity Therapeutics (NASDAQ:ATHE) has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), securing critical regulatory alignment on the design of its upcoming pivotal Phase 3 clinical program for lead candidate ATH434.

Lands' End (NASDAQ:LE) reported a substantial swing to first-quarter net profitability due to a major brand management transaction, shielding the company's bottom line from a drop in core e-commerce and retail revenue.

SailPoint (NASDAQ:SAIL) reported a 22% increase in first-quarter revenue, driven by robust enterprise adoption of its software-as-a-service identity management platforms amid tightening regulatory mandates for corporate data security.

CECO Environmental (NASDAQ:CECO) raised its full-year 2026 financial guidance, factoring in the initial operational contributions from its recently finalized acquisition of Thermon Group Holdings.

United Natural Foods (NYSE:UNFI) reported a return to profitability for the third quarter of fiscal year 2026, as targeted overhead reductions and warehouse optimization measures successfully offset a moderate contraction in top-line sales.

The J.M. Smucker Company (NYSE:SJM) reported a 20% increase in fourth-quarter adjusted earnings per share, driven by favorable pricing actions and portfolio management, while issuing a forward-looking forecast that projects a modest revenue contraction for the upcoming fiscal year.

Titan Machinery (NASDAQ:TITN) reported a double-digit decline in first-quarter revenue, swinging to a net loss as a broader cyclical slowdown in global agricultural and construction markets continues to weigh on heavy equipment retail volumes.

Burning Rock Biotech (NASDAQ:BNR) reported an 18.9% drop in first-quarter revenue for fiscal year 2026, as lower volumes across its core diagnostic testing and pharmaceutical services lines countered ongoing cost-containment measures.

Designer Brands (NYSE:DBI) reported a slight expansion in its first-quarter top-line revenue, driven by strong growth within its wholesale division that helped offset softening demand across its core brick-and-mortar storefront network.

Parsons (NYSE:PSN) has secured an additional $73 million contract from the Air Force Research Laboratory to continue supporting its Global Application Research, Development, Engineering and Maintenance (GARDEM) mission.

Nathan’s Famous (NASDAQ:NATH) reported higher top-line revenue for fiscal year 2026, driven by growth in its foodservice and franchise segments, even as surging input costs chipped away at overall profit margins ahead of its planned private ownership transition.